A sixty-seven-year-old male with moderate persistent asthma was diagnosed at the San
Francisco Veterans Affairs Health Care System with non-metastatic hepatocellular …

Nowadays, immune checkpoint inhibitors (ICI) have become the cornerstone of treatment for
many tumors, either as monotherapy or in combination with other therapies. However, these …

We congratulate Wang et al.[1] on their timely and informative review of the use of immune
checkpoint inhibitors in the treatment of lung cancer. Their review is critical reading for all …

Introduction: Checkpoint inhibitor immunotherapies are relatively novel options that have
greatly improved the prognosis for patients with advanced malignancies. These agents …

P349 Introduction: We present two patients that developed sarcoid-like reactions after
initiation of immunotherapy. The first patient presented with clear cell endometrial cancer …

A 67-year-old man was diagnosed with hepatocellular carcinoma (HCC), cT4N1M1. The
patient agreed to receive the first dose of nivolumab 120 mg (2.4 mg/kg) before sorafenib …

Discussion To date, several cases of immune checkpoint-induced sarcoidosis have been
reported, most occurring in melanoma patients treated with ipilimumab, a cytotoxic T …

Immune checkpoint inhibitor (ICI) treatment has dramatically revolutionized the landscape of
therapeutic approaches in multiple cancers, particularly, non-small-cell lung cancer …

An 85-year-old man was diagnosed with hepatocellular carcinoma (HCC) and was initially
treated with transarterial chemoembolization (TACE) and sorafenib. He was then switched to …

Background The use of immune checkpoint inhibitors (ICI) has revealed a new panel of
tumor response and adverse events. Immune-related sarcoidosis-like reactions is frequently …